Rethinking America’s Role in Global Health Services Trade
In the world of global healthcare services, Mode 2 exports—the cross-border flow of patients traveling abroad for care—have long defined the United States’ approach to international health engagement. Commonly referred to as medical tourism, this model centered on attracting high-value foreign patients to U.S. hospitals and specialty centers. For years, it was considered a lucrative export: patients paid out of pocket or through international insurers for complex procedures, world-class specialists, and advanced technologies unavailable in their home countries.
Then came the pandemic.
When borders closed and flights were grounded, the U.S. medical tourism industry came to a near standstill. COVID-19 didn’t just disrupt travel; it exposed the fragility of a model overly dependent on patient mobility. Hospitals that had invested heavily in international departments saw referral pipelines collapse overnight. Even as travel resumed, shifting payer priorities, tighter budgets, and the rapid expansion of regional centers of excellence around the world have made it clear: the medical tourism model, as it once existed, is not coming back.
Beyond Borders: The Rise of Multi-Modal Global Health Engagement
If the “death” of medical tourism is the end of one era, it’s also the beginning of another. The GATS (General Agreement on Trade in Services) framework defines four modes of cross-border health trade—and Mode 2 is only one of them. The future lies in leveraging all four:
- Mode 1 – Cross-Border Supply: Telemedicine, digital consultations, remote diagnostics, and AI-driven health services enable U.S. expertise to reach patients worldwide without anyone boarding a plane.
- Mode 2 – Consumption Abroad: Still relevant for highly specialized care, but likely to remain a niche rather than a growth engine.
- Mode 3 – Commercial Presence: Partnerships and joint ventures abroad—where U.S. providers bring know-how, standards, and technology to local markets—represent a scalable way to export excellence.
- Mode 4 – Movement of Professionals: Training, research collaboration, and temporary mobility of healthcare professionals strengthen global relationships and enhance knowledge exchange.
This broader, multi-modal approach reflects how healthcare globalization is evolving. Rather than waiting for patients to come to the U.S., forward-thinking providers are going to the patients—digitally, educationally, and institutionally.
The New Export Strategy for U.S. Providers
To thrive in this new environment, U.S. institutions must reframe “export” to include intellectual capital, data, technology, and collaboration—not just procedures performed on U.S. soil. Strategic investments in digital health platforms, international clinical trials, virtual education, and value-based partnerships can yield sustained global influence while reducing dependence on unpredictable travel patterns.
Additionally, payers and health systems worldwide are seeking cost-effective, quality-assured, and technologically enabled solutions—an area where U.S. innovation still holds competitive advantage. But that advantage will only endure if American providers step beyond the old medical tourism paradigm and embrace a diversified portfolio of global engagements.
Conclusion: The Rebirth of Global Health Trade
So, is this the death of medical tourism? Perhaps. But it’s also a rebirth—a shift from a narrow, transactional export model to a more resilient, integrated global health strategy. The pandemic was a stress test that revealed the limits of dependence on physical travel. The next generation of global health trade will be hybrid, data-driven, and partnership-based.
For U.S. providers, the question is no longer how many international patients can we attract? but rather, how can we deliver our expertise, technology, and values across borders—by every available mode?
Be sure to join moderator, Irving Stackpole for “Reframing the Global HealthScape for US Hospitals: Next-Gen Competitive Models” at the 2025 USCIPP ANNUAL MEETING, December 5, 2025, 10:45 AM-11:30 AM ET, with Elizabeth Ziemba, Founder and President, Medical Tourism Training, Inc. and Deepak Asudani, MD, International Medical Director, UC San Diego Health. Learn more: https://stackpoleassociates.com/2025-uscipp/